Younger adults with atrial fibrillation face higher rates of heart failure and stroke

FHS
April 24, 2024
10:14 am

The risk factor (RF) burden, clinical outcomes, and long-term survival among patients with atrial fibrillation (AF) under 65 years of age.

Early AMR pipeline looks beyond traditional antibiotics – Pharmaceutical Technology

Share this article Antimicrobial resistance (AMR) has been identified as a major global threat by the WHO. Image Credit: Inkoly / Shutterstock. Despite being tagged

March 21, 2024

Deciphering the Mysteries of the Human Microbiome

The Microsetta Initiative studies human microbiomes, analyzing diverse data to reveal links between microbes, diet, and health for improved public health.

October 8, 2024

Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Conference 28.05.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

May 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.